Examination of aminophenol-containing compounds designed as antiproliferative agents and potential atypical retinoids.

Abstract

Retinoic acid (RA, 1), an oxidized form of vitamin A, binds to retinoic acid receptors (RAR) and retinoid X receptors (RXR) to regulate gene expression and has important functions such as cell proliferation and differentiation. Synthetic ligands regarding RAR and RXR have been devised for the treatment of various diseases, particularly promyelocytic leukemia, but their side effects have led to the development of new, less toxic therapeutic agents. Fenretinide (4-HPR, 2), an aminophenol derivative of RA, exhibits potent antiproliferative activity without binding to RAR/RXR, but its clinical trial was discontinued due to side effects of impaired dark adaptation. Assuming that the cyclohexene ring of 4-HPR is the cause of the side effects, methylaminophenol was discovered through structure-activity relationship research, and p-dodecylaminophenol (p-DDAP, 3), which has no side effects or toxicity and is effective against a wide range of cancers, was developed. Therefore, we thought that introducing the motif carboxylic acid found in retinoids, could potentially enhance the anti-proliferative effects. Introducing chain terminal carboxylic functionality into potent p-alkylaminophenols significantly attenuated antiproliferative potencies, while a similar structural modification of weakly potent p-acylaminophenols enhanced growth inhibitory potencies. However, conversion of the carboxylic acid moieties to their methyl esters completely abolished the cell growth inhibitory effects of both series. Insertion of a carboxylic acid moiety, which is important for binding to RA receptors, abolishes the action of p-alkylaminophenols, but enhances the action of p-acylaminophenols. This suggests that the amido functionality may be important for the growth inhibitory effects of the carboxylic acids.

• Authors: Ramesh M Chingle, Masahiko Imai, Sarah Altman, Daisuke Saito, Noriko Takahashi, Terrence R Burke
• Journal: Bioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 82 Pg. 117214 (03 15 2023) ISSN: 1464-3391 [Electronic] England
• PMID: 36913882 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
• Copyright: Published by Elsevier Ltd.

Chemical References

• Retinoids
• Fenretinide
• Aminophenols
• Antineoplastic Agents
• Tretinoin
• Retinoid X Receptors

Topics

• Retinoids (pharmacology, chemistry)
• Fenretinide
• Aminophenols
• Antineoplastic Agents (pharmacology)
• Tretinoin (pharmacology)
• Retinoid X Receptors